Plasma Inflammatory Mediator Concentrations at ICU Admission in Dogs with Naturally Developing Sepsis

Journal of Veterinary Internal Medicine

Volumn 26, Issue 3, 2012, Pages 624-630

  Declue, A E ^a   Sharp, C R ^a,b   Harmon, M ^a,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarker; Infection; Inflammation; Systemic inflammatory response syndrome

Indexed keywords

BIOLOGICAL MARKER; CXCL1 CHEMOKINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; BLOOD; COMPARATIVE STUDY; DOG; DOG DISEASE; FEMALE; IMMUNOLOGY; INTENSIVE CARE UNIT; MALE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHEMOKINE CXCL1; DOG DISEASES; DOGS; FEMALE; INTENSIVE CARE UNITS; INTERLEUKIN-10; MALE; PROSPECTIVE STUDIES; ROC CURVE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; CANIS FAMILIARIS;

EID: 84860547733     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.00895.x     Document Type: Article

References (34)

1. Rau S, Kohn B, Richter C, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol 2007;36:253-260.
2. Luschini MA, Fletcher DJ, Schoeffler GL. Incidence of ionized hypocalcemia in septic dogs and its association with morbidity and mortality: 58 cases (2006-2007). J Vet Emerg Crit Care (San Antonio) 2010;20:406-412.
3. Hauptmann J, Walshaw R, Olivier N. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg 1997;26:393-397.
4. DeClue AE, Osterbur K, Bigio A, et al. Evaluation of serum NT-pCNP as a diagnostic and prognostic biomarker for sepsis in dogs. J Vet Intern Med 2011;25:453-459.
5. Calandra T, Baumgartner JD, Grau GE, et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990;161:982-987.
6. de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997;25:607-613.
7. Gogos CA, Drosou E, Bassaris HP, et al. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-180.
8. Martin C, Boisson C, Haccoun M, et al. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997;25:1813-1819.
9. Otto C, Drobatz K, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997;11:65-70.
10. Yu DH, Nho DH, Song RH, et al. High-mobility group box 1 as a surrogate prognostic marker in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care 2010;20:298-302.
11. Okano S, Yoshida M, Fukushima U, et al. Usefulness of systemic inflammatory response syndrome criteria as an index for prognosis judgement. Vet Rec 2002;150:245-246.
12. Giunti M, Peli A, Battilani M, et al. Evaluation of CALC-I gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) 2010;20:523-527.
13. Iris K, Leontides LS, Mylonakis ME, et al. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection. Res Vet Sci 2010;89:174-178.
14. Matijatko V, Kis I, Torti M, et al. Septic shock in canine babesiosis. Vet Parasitol 2009;162:263-270.
15. Osterbur K, Whitehead Z, Sharp CR, et al. Plasma nitrate/nitrite concentrations in dogs with naturally developing sepsis and non-infectious forms of the systemic inflammatory response syndrome. Vet Rec 2011;169:554.
16. DeClue AE, Cohn LA, Lechner ES, et al. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. Am J Vet Res 2008;69:228-232.
17. Deitschel SJ, Kerl ME, Chang CH, et al. Age-associated changes to pathogen-associated molecular pattern-induced inflammatory mediator production in dogs. J Vet Emerg Crit Care (San Antonio) 2010;20:494-502.
18. Fowler BL, Axiak SM, DeClue AE. Blunted pathogen-associated molecular pattern motif induced TNF, IL-6 and IL-10 production from whole blood in dogs with lymphoma. Vet Immunol Immunopathol 2011;144:167-71.
19. R and D Systems. Quantikine canine IL-10 immunoassay. Available at:. Accessed August 13, 2009.
20. R and D Systems. Quantikine canine CXCL-8/IL-8 immunoassay. Available at:. Accessed August 13, 2009.
21. R and D Systems. Quantikine canine IL-10 immunoassay. Available at:. Accessed October 12, 2009.
22. DeClue AE, Delgado C, Chang CH, et al. Clinical and immunologic assessment of sepsis and the systemic inflammatory response syndrome in cats. J Am Vet Med Assoc 2011;238:890-897.
23. Martins TL, Kahvegian MA, Noel-Morgan J, et al. Comparison of the effects of tramadol, codeine, and ketoprofen alone or in combination on postoperative pain and on concentrations of blood glucose, serum cortisol, and serum interleukin-6 in dogs undergoing maxillectomy or mandibulectomy. Am J Vet Res 2010;71:1019-26.
24. Gosain A, Gamelli RL. A primer in cytokines. J Burn Care Rehabil 2005;26:7-12.
25. Marty C, Misset B, Tamion F, et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-679.
26. Wong HR, Cvijanovich N, Wheeler DS, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008;178:276-282.
27. Inoue H, Hara M, Massion PP, et al. Role of recruited neutrophils in interleukin-8 production in dog trachea after stimulation with Pseudomonas in vivo. Am J Respir Cell Mol Biol 1995;13:570-577.
28. Inoue H, Massion PP, Ueki IF, et al. Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils. Am J Respir Cell Mol Biol 1994;11:651-663.
29. Martin K, Viera K, Petr C, et al. Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique and of probabilities of measurable concentrations of interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occurring in plasma of healthy blood donors. Mediators Inflamm 2006;2006:65237.
30. Zois NE, Moesgaard SG, Kjelgaard-Hansen M, et al. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease. Vet J 2011; Epub Jun 20.
31. de Laforcade AMRE, Freeman LM, Li W. Serial evaluation of protein C and antithrombin in dogs with sepsis. J Vet Intern Med 2008;22:26-30.
32. de Laforcade AMFL, Shaw SP, Brooks MB, et al. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003;17:674-679.
33. Burkitt J, Haskins S, Nelson R, et al. Relative adrenal insufficiency in dogs with sepsis. J Vet Intern Med 2007;21:226-231.
34. Webb CMK, Dow S. Neutrophil function in septic dogs. J Vet Intern Med 2007;21:982-989.